NCT00365261View on ClinicalTrials.gov

Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Sleep Initiation and Maintenance Disorders
Interventions
DRUG

Eszopiclone

eszopiclone 2 to 3 mg po at bedtime

DRUG

Placebo

placebo 2 to 3 mg po at bedtime

Trial Locations (1)

92037

UCSD Thornton Hospital, La Jolla

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT00365261 - Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer | Biotech Hunter | Biotech Hunter